Suppression of HIV in the first 12 months of antiretroviral therapy: a comparative analysis of dolutegravir- and efavirenz-based regimens

Suppression of HIV in the first 12 months of antiretroviral therapy: a comparative analysis of dolutegravir- and efavirenz-based regimens

ABSTRACT Objective To compare viral suppression in treatment-naïve adults starting antiretroviral therapy with dolutegravir (50mg)- and efavirenz (600mg)-based regimens. Methods We analyzed secondary data from Brazilian health information systems of people living with human immunodeficiency viru...

Full description

Bibliographic Details
Main Authors: Gabriella Jomara da Silva, Cássia Cristina Pinto Mendicino, Cristiane Aparecida Menezes de Pádua, Unaí Tupinambás
Format: Article
Language:English
Published: Instituto Israelita de Ensino e Pesquisa Albert Einstein 2023-05-01
Series:Einstein (São Paulo)
Subjects:
HIV-1
Viral load
Sustained virologic response
Effectiveness
Dolutegravir
Efavirenz
Drug therapy, combination
Antiretroviral therapy, highly active
Anti-HIV agents
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082023000100213&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1679-45082023000100213&lng=en&tlng=en

Similar Items